CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, F.
Right arrow Articles by Friedman, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, F.
Right arrow Articles by Friedman, E.

Cell Growth & Differentiation, Vol 6, Issue 12 1635-1642, Copyright © 1995 by American Association of Cancer Research


ARTICLES

Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid

F Huang, E Newman, D Theodorescu, RS Kerbel and E Friedman
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

A transforming growth factor beta1 (TGF beta1) antisense expression plasmid under constitutive control of the Rous sarcoma virus promoter was introduced into the highly tumorigenic and invasive colon carcinoma U9A cell line, which uses its autocrine TGF beta1 as a growth-stimulating factor. Stable transfectants were infrequent, and only the K6 transfectant exhibited 39 and 33%, respectively, of the levels of TGF beta1 mRNA and active, secreted TGF beta1 protein of the parental line. K6 exhibited no change in TGF beta2 expression, and TGF beta3 expression was not detected in either parental or transfectant cells. Compared to the parental line, the K6 antisense transfectant exhibited a 3-fold increase in lag time in anchorage-dependent colony formation. The parental line was 44 times as invasive through a collagen l-coated polycarbonate membrane in vitro as K6 cells and, after s.c. injection at low-cell inocula, U9A cells induced tumors 75 times as large in vivo as did the K6 antisense transfectant. The decreases in in vitro invasion and anchorage-dependent colony formation seen in K6 cells were largely reversed by the addition of TGF beta1. Tumors that did arise from the K6 antisense transfectant cells had lost antisense TGF beta1 expression and expressed the same TGF beta1 mRNA levels as controls. U9A cells were more metastatic to the liver after intrasplenic injection than K6 cells. These findings demonstrate a role for autocrine TGE beta1 in colon cancer tumorigenicity and invasion. They also show that a relatively small decrease in TGF beta1 levels was enough to markedly decrease colon carcinoma cell aggressiveness. This is not unprecedented, as we had found in an earlier study that a small, 2-4-fold increase in TGF beta1 protein levels in human colon cancers correlated with disease progression to metastases (E. Friedman et al., Cancer Epidemiol, Biomarkers & Prev., 4:549-554, 1995).


This article has been cited by other articles:


Home page
J Biol ChemHome page
S.-R. Shiou, P. K. Datta, P. Dhawan, B. K. Law, J. M. Yingling, D. A. Dixon, and R. D. Beauchamp
Smad4-dependent Regulation of Urokinase Plasminogen Activator Secretion and RNA Stability Associated with Invasiveness by Autocrine and Paracrine Transforming Growth Factor-beta
J. Biol. Chem., November 10, 2006; 281(45): 33971 - 33981.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
A Wimmel, B Wiedenmann, and S Rosewicz
Autocrine growth inhibition by transforming growth factor {beta}-1 (TGF{beta}-1) in human neuroendocrine tumour cells
Gut, September 1, 2003; 52(9): 1308 - 1316.
[Abstract] [Full Text]


Home page
J Biol ChemHome page
Z. Yan, G.-Y. Kim, X. Deng, and E. Friedman
Transforming Growth Factor {beta}1 Induces Proliferation in Colon Carcinoma Cells by Ras-dependent, smad-independent Down-regulation of p21cip1
J. Biol. Chem., March 22, 2002; 277(12): 9870 - 9879.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W.-M. Miao, W. Lin Seng, M. Duquette, P. Lawler, C. Laus, and J. Lawler
Thrombospondin-1 Type 1 Repeat Recombinant Proteins Inhibit Tumor Growth through Transforming Growth Factor-{beta}-dependent and -independent Mechanisms
Cancer Res., November 1, 2001; 61(21): 7830 - 7839.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Tsushima, N. Ito, S. Tamura, Y. Matsuda, M. Inada, I. Yabuuchi, Y. Imai, R. Nagashima, H. Misawa, H. Takeda, et al.
Circulating Transforming Growth Factor {beta}1 as a Predictor of Liver Metastasis after Resection in Colorectal Cancer
Clin. Cancer Res., May 1, 2001; 7(5): 1258 - 1262.
[Abstract] [Full Text]


Home page
J Biol ChemHome page
Z. Yan, X. Deng, and E. Friedman
Oncogenic Ki-ras Confers a More Aggressive Colon Cancer Phenotype through Modification of Transforming Growth Factor-{beta} Receptor III
J. Biol. Chem., January 12, 2001; 276(2): 1555 - 1563.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Ananth, B. Knebelmann, W. Gruning, M. Dhanabal, G. Walz, I. E. Stillman, and V. P. Sukhatme
Transforming Growth Factor {beta}1 Is a Target for the von Hippel-Lindau Tumor Suppressor and a Critical Growth Factor for Clear Cell Renal Carcinoma
Cancer Res., May 1, 1999; 59(9): 2210 - 2216.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
Y. Maehara, Y. Kakeji, A. Kabashima, Y. Emi, A. Watanabe, K. Akazawa, H. Baba, S. Kohnoe, and K. Sugimachi
Role of Transforming Growth Factor-{beta}1 in Invasion and Metastasis in Gastric Carcinoma
J. Clin. Oncol., February 1, 1999; 17(2): 607 - 607.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Zhou, P. Buckhaults, L. Zawel, F. Bunz, G. Riggins, J. Le Dai, S. E. Kern, K. W. Kinzler, and B. Vogelstein
Targeted deletion of Smad4 shows it is required for transforming growth factor {beta} and activin signaling in colorectal cancer cells
PNAS, March 3, 1998; 95(5): 2412 - 2416.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
Z. Yan, X. Deng, and E. Friedman
Oncogenic Ki-ras Confers a More Aggressive Colon Cancer Phenotype through Modification of Transforming Growth Factor-{beta} Receptor III
J. Biol. Chem., January 12, 2001; 276(2): 1555 - 1563.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1995 by the American Association of Cancer Research.